# NU Skin Enterprises, Inc.: Form 10-Q for the period ended Jun 30, 2015

- Company: [NU Skin Enterprises, Inc.](/companies/nus.md) (CIK 1021561)
- Form: 10-Q
- Filed: 2015-08-07
- Accepted by EDGAR: Aug 6, 2015, 19:17 ET
- Period: 2015-06-30
- Accession: 0001021561-15-000062
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1021561/000102156115000062/form10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1021561/000102156115000062/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2015-04-01 to 2015-06-30 | $110.3m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months, 2015-01-01 to 2015-06-30 | $215.3m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2015-04-01 to 2015-06-30 | $449.9m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2015-01-01 to 2015-06-30 | $888.2m | us-gaap:GrossProfit |
| Operating income | 3 months, 2015-04-01 to 2015-06-30 | $71.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2015-01-01 to 2015-06-30 | $140.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2015-04-01 to 2015-06-30 | $24.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2015-01-01 to 2015-06-30 | $44.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2015-04-01 to 2015-06-30 | $44.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2015-01-01 to 2015-06-30 | $80.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2015-04-01 to 2015-06-30 | $0.75 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2015-01-01 to 2015-06-30 | $1.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-04-01 to 2015-06-30 | $0.76 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2015-01-01 to 2015-06-30 | $1.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-04-01 to 2015-06-30 | 59,713,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2015-01-01 to 2015-06-30 | 59,994,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2015-01-01 to 2015-06-30 | $159.6m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months, 2015-01-01 to 2015-06-30 | $34.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2015-01-01 to 2015-06-30 | $41.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2015-01-01 to 2015-06-30 | $75.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2015-06-30 | $292.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-06-30 | $807.7m | us-gaap:AssetsCurrent |
| Total assets | at 2015-06-30 | $1.60bn | us-gaap:Assets |
| Current liabilities | at 2015-06-30 | $420.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-06-30 | $698.7m | us-gaap:Liabilities |
| Long-term debt | at 2015-06-30 | $177.2m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2015-06-30 | $75.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2015-06-30 | $903.9m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 31,407 characters.

This quarterly report on Form 10-Q (this "Quarterly Report") contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent our current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding our performance, initiatives, strategies, product introductions and offerings, opportunities and risks; statements of projections regarding future sales, expenses, operating results, taxes and duties, capital expenditures, sources and uses of cash, foreign currency fluctuations or devaluations, and other financial items; statements of management's expectations and beliefs regarding the Company's markets; statements regarding the payment of future dividends and stock repurchases; statements regarding the outcome of litigation, audits or investigations; accounting estimates and assumptions; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. We caution and advise readers that these statements are based on assumptions that may not be realized and involve risks and uncertainties that could cause actual results to differ materially from the expectations and beliefs contained herein. For a summary of these risks, see "Item 1A – Risk Factors" of this Quarterly Report, as well as the risk factors included in our Annual Report on Form 10-K for the year ended December 31, 2014 and in subsequent Quarterly Reports on Form 10-Q (our "Periodic Reports").

The following Management's Discussion and Analysis should be read in conjunction with our consolidated financial statements and related notes, Management's Discussion and Analysis included in our Periodic Reports, and our other filings, including Current Reports on Form 8-K, filed with the Securities and Exchange Commission through the date of this report.

### Overview

Revenue for the three-month period ended June 30, 2015 decreased 14% to $560.2 million, compared to the prior-year period, and revenue for the six-month period ended June 30, 2015 decreased 16% to $1.1 billion, compared to the prior-year period. Foreign currency fluctuations negatively impacted revenue 7% in both periods, and we currently expect that the stronger U.S. dollar will continue to impact our results in 2015. Revenue comparisons for the second quarter and first half were impacted by approximately $76 million and $109 million, respectively, in limited-time offer sales in the prior-year periods, with no significant limited-time offers during the first half of the current year. Sales Leaders and Actives for the quarter were down 1% and 6%, respectively, compared to the prior year.

Earnings per share for the second quarter and first half of 2015 were $0.75 and $1.35, respectively, compared to $0.32 and $1.22 for the prior-year periods. The year-over-year increase in earnings per share reflects two significant charges taken in 2014: a $46.3 million charge in the first half of 2014 resulting from the impact of the devaluation of the Venezuelan currency on the monetary assets and liabilities of our Venezuela entity, $25.3 million of which related to the second quarter of 2014, and a $50.0 million charge for the write-down of inventory, primarily in Mainland China, in the second quarter of 2014.

We expect that our revenue for the remainder of 2015 and for 2016 will be positively impacted by the introduction of new products. We currently plan to introduce our *ageLOC Youth* nutritional supplement and our *ageLOC Me* personalized skin care system in certain markets during the third and fourth quarters of 2015 and continuing into 2016. We also plan to launch our cosmetic oil products later this year under our ageLOC brand in the Greater China region and our Epoch® essential oils in certain markets in the South Asia/Pacific and EMEA regions.

### Revenue

Greater China. The following table sets forth revenue for the three- and six-month periods ended June 30, 2015 and 2014 for the Greater China region and its principal markets (U.S. dollars in millions):

|  | Three Months Ended June 30, 2015 | 2014 | Change | Six Months Ended June 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Mainland China | $ 149.2 | $ 153.8 | (3%) | $ 283.4 | $ 366.0 | (23%) |
| Taiwan/Hong Kong | 50.9 | 76.1 | (33%) | 104.1 | 142.8 | (27%) |
| Greater China total | $ 200.1 | $ 229.9 | (13%) | $ 387.5 | $ 508.8 | (24%) |

Foreign currency fluctuations did not impact revenue in this region for the three-month period ended June 30, 2015, and negatively impacted revenue 1% during the six-month period ended June 30, 2015, compared to the prior-year periods. Sales Leaders and Actives in Mainland China increased 2% and decreased 16%, respectively, compared to the prior-year quarter. Sales Leaders and Actives in Taiwan were down 9% and 17%, respectively, and in Hong Kong they were down 12% and 16%, respectively, compared to the prior-year quarter.

The year-over-year revenue decline for the quarter reflects approximately $55 million in revenue in this region in the second quarter of 2014 generated by a limited-time offer of *ageLOC Tru Face Essence Ultra* and *TR90*. The decline for the six-month period also reflects an additional approximately $15 million of revenue in the first quarter of 2014 from the final phase of our global limited-time offer of *TR90* in the Greater China region, and the disruption of our business in Mainland China that has impacted results in the region.

Sequentially, Sales Leaders and Actives in the Greater China region increased 15% and decreased 9%, respectively, from the first quarter of 2015. We believe the increase in Sales Leaders reflects enthusiasm for upcoming product launches in the region.

We currently plan to launch our *ageLOC Essentials* line of cosmetic oils in this region later this year.

North Asia. The following table sets forth revenue for the three- and six-month periods ended June 30, 2015 and 2014 for the North Asia region and its principal markets (U.S. dollars in millions):

|  | Three Months Ended June 30, 2015 | 2014 | Change | Six Months Ended June 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| South Korea | $ 109.0 | $ 118.8 | (8%) | $ 217.8 | $ 232.8 | (6%) |
| Japan | 63.9 | 77.2 | (17%) | 127.2 | 158.7 | (20%) |
| North Asia total | $ 172.9 | $ 196.0 | (12%) | $ 345.0 | $ 391.5 | (12%) |

Revenue in the region for the three- and six-month periods ended June 30, 2015 was negatively impacted approximately 10% and 8%, respectively, by foreign currency fluctuations compared to the prior-year periods. Foreign currency fluctuations negatively impacted revenue 6% and 16% in South Korea and Japan, respectively, for the second quarter of 2015, and 4% and 14% for the first half of 2015, compared to the same prior-year periods.

Local-currency revenue in South Korea was down 2% for both the three- and six-month periods ended June 30, 2015, compared to the prior-year periods. Our Sales Leaders and Actives in South Korea increased 5% and decreased 2%, respectively, compared to the prior-year period. Concerns related to recent cases of Middle East Respiratory Syndrome caused temporary disruption of our sales force and business meetings in this region during the quarter.

Local-currency revenue in Japan during the second quarter of 2015 decreased 2%, compared to the same period in 2014, and decreased 6% for the first half of 2015, compared to the first half of 2014. Sales Leaders and Actives in Japan decreased 8% and 1%, respectively, compared to the second quarter of 2014, reflecting challenges related to the difficult direct selling environment in Japan. We continue to be cautious in our promotional activities in Japan.

We currently plan to introduce our *ageLOC Me* personalized skin care system in this region during the fourth quarter of 2015.

Americas. The following table sets forth revenue for the three- and six-month periods ended June 30, 2015 and 2014 for the Americas region and its principal markets (U.S. dollars in millions):

|  | Three Months Ended June 30, 2015 | 2014 | Change | Six Months Ended June 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| United States/Canada | $ 68.6 | $ 72.6 | (6%) | $ 137.2 | $ 139.1 | (1%) |
| Latin America | 14.9 | 17.3 | (14%) | 26.1 | 30.7 | (15%) |
| Americas total | $ 83.5 | $ 89.9 | (7%) | $ 163.3 | $ 169.8 | (4%) |

Revenue in the region for the three- and six-month periods ended June 30, 2015 was negatively impacted 13% and 16% by foreign currency fluctuations compared to the same prior-year periods. Strong local-currency growth in Latin America was offset by the continued devaluation of the Venezuelan currency and the weakening of other currencies against the U.S. dollar. The year-over-year comparisons are also negatively impacted by approximately $11 million in sales generated by the limited-time offer of *TR90* in the Americas during the second quarter of 2014. Second-quarter revenue in 2015 was positively impacted by a promotional offering of our essential oil products in the United States and Canada. We subsequently launched our essential oil products in these markets at the end of June 2015.

Sales Leaders and Actives in the Americas region increased by 4% and decreased by 5%, respectively, when compared to the prior year.

We currently plan to introduce our *ageLOC Youth* nutritional supplement in this region later this year.

South Asia/Pacific. The following table sets forth revenue for the three- and six-month periods ended June 30, 2015 and 2014 for the South Asia/Pacific region (U.S. dollars in millions):

|  | Three Months Ended June 30, 2015 | 2014 | Change | Six Months Ended June 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| South Asia/Pacific | $ 68.0 | $ 81.7 | (17%) | $ 138.8 | $ 152.8 | (9%) |

Foreign currency fluctuations in South Asia/Pacific negatively impacted revenue 8% and 7%, respectively, in the three- and six-month periods ended June 30, 2015, compared to the same prior-year periods. Softness throughout most of the region during the second quarter of 2015 was partially offset by growth in Indonesia and Vietnam. We believe this softness was due in part to a lack of new product initiatives, as our new product initiatives are scheduled for the second half of the year. Sales Leaders in the region decreased 2% and Actives remained even compared to the prior year.

We currently plan to introduce our *ageLOC Youth* nutritional supplement in certain markets of this region during the third quarter of 2015.

EMEA. The following table sets forth revenue for the three- and six-month periods ended June 30, 2015 and 2014 for the Europe, Middle East and Africa ("EMEA") region (U.S. dollars in millions):

|  | Three Months Ended June 30, 2015 | 2014 | Change | Six Months Ended June 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| EMEA | $ 35.6 | $ 52.6 | (32%) | $ 68.8 | $ 98.2 | (30%) |

Foreign currency fluctuations in the EMEA region negatively impacted revenue by 17% in both the three- and six-month periods ended June 30, 2015, compared to the same prior-year periods. The year-over-year comparisons also reflect approximately $8 million in sales generated by our limited-time offer of *TR90* in EMEA during the second quarter of 2014. Revenue was also negatively impacted by a decline in Sales Leaders and Actives of 10% and 7%, respectively, when compared to the second quarter of 2014, which we believe was due in part to a lack of new product initiatives, as our new product initiatives are scheduled for the second half of the year.

We currently plan to introduce our *ageLOC Me* personalized skin care system later this year in this region.

### Gross profit

Gross profit as a percentage of revenue was 80.3% in the second quarter of 2015 and 80.5% in the first half of 2015, compared to 76.0% and 80.1% in the same prior-year periods. The year-over-year increase reflects a $50.0 million write-down of inventory, primarily in Mainland China, in the second quarter of 2014. The impact of this inventory write-down was partially offset by the 2015 reclassification of certain overhead expenses related to warehousing and shipping products from general and administrative expense to cost of sales. The amount that was reclassified from general and administrative expense to cost of sales was $7.6 million for the second quarter of 2015 and $8.3 million for the first quarter of 2015. We did not revise prior-period financial statements because the reclassification was not material to the prior periods.

### Selling expenses

Selling expenses as a percentage of revenue decreased to 42.7% for the three-month period ended June 30, 2015 from 43.6% for the same period in 2014. Selling expenses as a percentage of revenue decreased to 42.9% for the six-month period ended June 30, 2015 from 45.2% for the same period in 2014. Selling expenses as a percentage of revenue in the first half of 2015 were lower due to a reduction in the number of Sales Leaders qualifying for incentive trips and other promotional incentives. In addition, the salaries of our sales employees in Mainland China are fixed for a three-month period of time, until they are adjusted during a quarterly evaluation process. Consequently, our selling expenses as a percentage of revenue were relatively high in the first quarter of 2014 because a portion of our sales compensation remained fixed while our revenue was negatively impacted by the voluntary measures we took in Mainland China during that quarter.

### General and administrative expenses

General and administrative expenses decreased to $138.7 million in the second quarter of 2015 and $274.3 in the first half of 2015, compared to $155.7 million and $305.8 in the respective prior-year periods. As a percentage of revenue, general and administrative expenses increased to 24.8% and 24.9% for the three- and six-month periods ended June 30, 2015 from 24.0% and 23.2% for the same periods in 2014. General and administrative expenses were impacted by the 2015 reclassification of overhead expenses from general and administrative expense into cost of sales as discussed under "Gross profit" above. In addition, we reduced our general and administrative expenses, such as labor expenses and promotional activities, as revenue declined.

### Other income (expense), net

Other income (expense), net for the three- and six-month periods ended June 30, 2015 was $2.8 million of expense and $15.0 million of expense, respectively, compared to $21.1 million of expense and $38.6 million of expense for the same periods in 2014. These year-over-year decreases in expense were largely due to a first-half 2014 foreign currency charge of $46.3 million resulting from the impact of the devaluation of the Venezuelan currency on the monetary assets and liabilities of our Venezuela entity, $25.3 million of which related to the second quarter of 2014. We similarly incurred a $10.2 million foreign currency charge related to Venezuela during the first quarter of 2015. For more information about these charges, see "—Liquidity and Capital Resources."

### Provision for income taxes

Provision for income taxes for the three- and six-month periods ended June 30, 2015 was $24.4 million and $44.5 million, compared to $14.1 million and $42.9 million for the same periods in 2014. The effective tax rate was 35.3% and 35.5%, respectively, of pre-tax income during the three- and six-month periods ended June 30, 2015, compared to 42.0% and 36.6% in the same prior-year periods. The decrease in the effective tax rate in 2015 was due largely to the impact of the 2014 foreign currency charge related to Venezuela, for which a deductible tax expense is not allowed until profit is realized in that market.

### Net income

As a result of the foregoing factors, net income for the second quarter and first half of 2015 was $44.7 million and $80.9 million, respectively, compared to $19.5 million and $74.4 million, respectively, for the same periods in 2014.

### Liquidity and Capital Resources

Historically, our principal uses of cash have included operating expenses, particularly selling expenses, and working capital (principally inventory purchases), as well as capital expenditures, stock repurchases, dividends, debt repayment and the development of operations in new markets. We have at times incurred long-term debt in order to fund strategic transactions and stock repurchases. We typically generate positive cash flow from operations due to favorable margins and have generally relied on cash from operations to fund operating activities. We generated $159.6 million in cash from operations during the first half of 2015, compared to a net outflow of $184.9 million in cash from operations during the prior-year period. The increase in cash generated from operations reflects two significant uses of cash in the first half of 2014: (1) the payment of a significant amount of expenses that were accrued as of the end of 2013, following a quarter of record sales and a record number of sales representatives who qualified for incentive trips; and (2) payments to build up a large amount of inventory for planned product launches in 2014, increasing our inventory balance by a net $50.0 million from December 31, 2013 to June 30, 2014. Our inventory balance decreased by a net $33.5 million from December 31, 2014 to June 30, 2015.

As of June 30, 2015, working capital was $387.0 million, compared to $416.3 million as of December 31, 2014. Cash and cash equivalents, including current investments, as of June 30, 2015 and December 31, 2014 were $303.9 million and $300.2 million, respectively.

Capital expenditures in the first half of 2015 were $34.8 million, and we anticipate additional capital expenditures of approximately $35 million for the remainder of 2015. Our 2015 capital expenditures are primarily related to:

- purchases of computer systems and software, including equipment and development costs;
- the expansion and upgrade of facilities in our various markets; and
- purchase of tooling and manufacturing equipment related to the development of new products.

Our Credit Agreement (the "Credit Agreement") with various financial institutions, and Bank of America, N.A. as administrative agent, provides for a $127.5 million term loan facility, a 6.6 billion Japanese yen term loan facility and a $187.5 million revolving credit facility, each with a term of five years. The Credit Agreement requires that we maintain a consolidated leverage ratio not exceeding 2.25 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. As of June 30, 2015, we had debt pursuant to the Credit Agreement of $232.1 million, consisting of $122.7 million and 6.3 billion Japanese yen ($51.8 million) under the term loan facilities and $62.5 million under the revolving credit facility, less a debt discount of $4.9 million. Please refer to Note 10 to the consolidated financial statements contained in this report for further information regarding the Credit Agreement and other debt.

Our board of directors has approved a stock repurchase program authorizing us to repurchase our outstanding shares of Class A common stock on the open market or in private transactions. The repurchases are used primarily to offset dilution from our equity incentive plans and for strategic initiatives. During the first half of 2015, we repurchased 1.4 million shares of Class A common stock under this program for $75.9 million. As of June 30, 2015, $271.5 million was available for repurchases under the stock repurchase program.

In January and April 2015, our board of directors declared a quarterly cash dividend of $0.35 per share. These quarterly cash dividends of $20.7 million and $20.5 million were paid on March 18, 2015 and June 10, 2015 to stockholders of record on February 27, 2015 and May 22, 2015. In August 2015, our board of directors declared a quarterly cash dividend of $0.35 per share to be paid on September 16, 2015 to stockholders of record on August 28, 2015. Currently, we anticipate that our board of directors will continue to declare quarterly cash dividends and that the cash flows from operations will be sufficient to fund our future dividend payments. However, the continued declaration of dividends is subject to the discretion of our board of directors and will depend upon various factors, including our net earnings, financial condition, cash requirements, future prospects and other relevant factors.

As of June 30, 2015 and December 31, 2014, we held $303.9 million and $300.2 million, respectively, in cash and cash equivalents, including current investments. Cash and cash equivalents includes $244.4 million and $195.7 million as of June 30, 2015 and December 31, 2014, respectively, held in our operations outside of the U.S. Substantially all of our non-U.S. cash and cash equivalents are readily convertible into U.S. dollars or other currencies, with the exception of cash in Venezuela which is subject to currency exchange restrictions by the government of Venezuela. Currency exchange restrictions in Venezuela require approval from the government's currency control organization for our subsidiary in Venezuela to obtain U.S. dollars at an official exchange rate to pay for imported products or to repatriate dividends to the United States. We have been unsuccessful in obtaining U.S. dollars at the official exchange rates and under alternative exchange mechanisms described below. As a result, these foreign exchange controls in Venezuela have limited our ability to repatriate earnings and settle our intercompany obligations, which has resulted in the accumulation of bolivar denominated cash and cash equivalents in Venezuela.

During the first quarter of 2014, two new foreign exchange mechanisms ("SICAD I" and "SICAD II") became available in Venezuela. As of March 31, 2014, we determined it would be most appropriate to utilize the SICAD I rate, which was approximately 10.7 bolivars per U.S. dollar. As a result, we incurred a $14.7 million charge related to the translation of our monetary assets in Venezuela. During the second quarter, we determined that it would be most appropriate to use the SICAD II rate, which is approximately 50 bolivars per U.S. dollar, as we had still not received any approvals under SICAD I. The remeasurement of our net monetary assets and liabilities denominated in bolivars as a result of this change resulted in a foreign exchange loss of $25.3 million during the three months ended June 30, 2014. During the first quarter of 2015, Venezuela announced that it merged its SICAD I and SICAD II mechanisms into a single mechanism ("SICAD"), which is 12 bolivars per U.S. dollar, and it announced a new foreign exchange mechanism ("SIMADI"), which utilizes a variable exchange rate that was approximately 193 bolivars per U.S. dollar as of March 31, 2015. During the first quarter, we determined it would be most appropriate to utilize the SIMADI rate. The remeasurement of our net monetary assets and liabilities denominated in bolivars as a result of this change resulted in a foreign currency exchange loss of $10.2 million during the first quarter of 2015. As of June 30, 2015, cash and cash equivalents in Venezuela were $2.6 million. Based on the amount of cash we have in this market and the actions we have taken to date, we believe the risks in this market have largely been mitigated.

We typically fund the cash requirements of our operations in the U.S. through intercompany charges for products, license fees and corporate services. However, in some markets such as Mainland China, where we have lower intercompany charges, we may be unable to repatriate cash from current operations in the form of dividends until we file the necessary statutory financial statements for the relevant period. We currently have in place an intercompany loan arrangement, which allows us to access a portion of available cash in Mainland China pending our repatriation of dividends. As of June 30, 2015, we had $75.3 million in cash denominated in Chinese RMB. We currently plan to repatriate undistributed earnings from our non-U.S. operations as necessary, considering the cash needs of our non-U.S. operations and the cash needs of our U.S. operations for dividends, stock repurchases, capital investments, debt repayment and strategic transactions. Except for partial indefinite reinvestment in two jurisdictions, we have not designated our investments as indefinitely reinvested, but rather have these funds available for our operations in the U.S. as needed. Any repatriation of non-U.S. earnings requires payment of U.S. taxes in accordance with applicable U.S. tax rules and regulations. Accordingly, we have accrued the necessary U.S. taxes related to the funds that are not indefinitely reinvested.

We currently believe that existing cash balances, future cash flows from operations and existing lines of credit will be adequate to fund our cash needs on both a short- and long-term basis. The majority of our historical expenses have been variable in nature and as such, a potential reduction in the level of revenue would reduce our cash flow needs. In the event that our current cash balances, future cash flow from operations and current lines of credit are not sufficient to meet our obligations or strategic needs, we would consider raising additional funds in the debt or equity markets or restructuring our current debt obligations. Additionally, we would consider realigning our strategic plans, including a reduction in capital spending, stock repurchases or dividend payments.

### Contingent Liabilities

Please refer to Note 9 to the consolidated financial statements contained in this report for information regarding our contingent liabilities.

### Critical Accounting Policies

There were no significant changes in our critical accounting policies during the quarter ended June 30, 2015.

### Seasonality and Cyclicality

In addition to general economic factors, we are impacted by seasonal factors and trends such as major cultural events and vacation patterns. For example, most Asian markets celebrate their respective local New Year in the first quarter, which generally has a negative impact on that quarter. We believe that direct selling is also generally negatively impacted during the third quarter, when many individuals, including our sales force, traditionally take vacations.

Although our product launch process may vary by market, we generally introduce new key products to our sales force and consumers through limited-time offers. The limited-time offers typically generate significant activity and a high level of purchasing, which may result in a higher than normal increase in revenue during the quarter of the limited-time offer and skew year-over-year and sequential comparisons.

### Actives and Sales Leaders

The following table provides information concerning the number of Actives and Sales Leaders as of the dates indicated. "Actives" are persons who have purchased products directly from the Company during the three months ended as of the date indicated. "Sales Leaders" are independent distributors, and sales employees and independent marketers in China, who achieve certain qualification requirements.

| Region: | As of June 30, 2015 Actives | Sales Leaders | As of June 30, 2014 Actives | Sales Leaders |
| --- | ---: | ---: | ---: | ---: |
| Greater China | 215,000 | 25,956 | 256,000 | 26,192 |
| North Asia | 387,000 | 16,991 | 393,000 | 17,186 |
| Americas | 180,000 | 7,892 | 189,000 | 7,627 |
| South Asia/Pacific | 120,000 | 7,279 | 120,000 | 7,450 |
| EMEA | 113,000 | 4,042 | 121,000 | 4,468 |
| Total | 1,015,000 | 62,160 | 1,079,000 | 62,923 |

### Currency Risk and Exchange Rate Information

A majority of our revenue and many of our expenses are recognized outside of the United States, except for inventory purchases, a significant portion of which are primarily transacted in U.S. dollars from vendors in the United States. The local currency of each of our Subsidiaries' primary markets is considered the functional currency with the exception of our Asia product-distribution subsidiary in Singapore and our Venezuela subsidiary. All revenue and expenses are translated at weighted-average exchange rates for the periods reported. Therefore, our reported revenue and earnings will be positively impacted by a weakening of the U.S. dollar and will be negatively impacted by a strengthening of the U.S. dollar. Given the large portion of our business derived from Mainland China, South Korea and Japan, any weakening of these currencies negatively impacts reported revenue and profits, whereas a strengthening of these currencies positively impacts our reported revenue and profits. Given the uncertainty of exchange rate fluctuations, it is difficult to predict the effect of these fluctuations on our future business, product pricing and results of operations or financial condition. During 2014 and the first half of 2015, the strengthening of the U.S. dollar against other currencies significantly impacted our financial results.

We may seek to reduce our exposure to fluctuations in foreign currency exchange rates through the use of foreign currency exchange contracts and through intercompany loans of foreign currency. We do not use derivative financial instruments for trading or speculative purposes. We regularly monitor our foreign currency risks and periodically take measures to reduce the impact of foreign exchange fluctuations on our operating results. As of June 30, 2015, we held forward contracts designated as foreign currency cash flow hedges with notional amounts totaling approximately 1.3 billion Japanese yen ($10.6 million as of June 30, 2015) and 15.0 million euros ($13.5 million as of June 30, 2015) to hedge forecasted foreign-currency-denominated intercompany transactions; and at June 30, 2014, we held forward contracts designated as foreign currency cash flow hedges with notional amounts totaling approximately 1.9 billion Japanese yen ($18.7 million as of June 30, 2014) and 10.0 million euros ($13.7 million as of June 30, 2014). Because of our foreign exchange contracts at June 30, 2015, the impact of a 10% appreciation or 10% depreciation of the U.S. dollar against the Japanese yen would not represent a material potential loss in fair value, earnings or cash flows against these contracts. This potential loss does not consider the underlying foreign currency transaction or translation exposures to which we are subject.

## Market risk

As filed, 359 characters.

The information required by Item 3 of Part I of Form 10-Q is incorporated herein by reference from the section entitled "Currency Risk and Exchange Rate Information" in "Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operation" of Part I and also in Note 4 to the consolidated financial statements contained in this report.

## Controls and procedures

As filed, 958 characters.

### Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report, under the supervision and with the participation of our management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")). Based on that evaluation, our CEO and our CFO concluded that our disclosure controls and procedures were effective as of June 30, 2015.

### Changes in Internal Controls Over Financial Reporting.

We made no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the fiscal quarter ended June 30, 2015 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 3,037 characters.

The information presented below supplements and should be read in conjunction with the detailed discussion of risks associated with our business in our recent SEC filings, including our Annual Report on Form 10-K for the 2014 fiscal year and our Quarterly Report on Form 10-Q for the 2015 first quarter.

**Production difficulties, quality control problems and inaccurate forecasting could harm our business.**

Production difficulties and quality control problems and our reliance on third party suppliers to manufacture and deliver products that meet our specifications in a timely manner could harm our business. Occasionally, we have experienced production difficulties with respect to our products, including the availability of raw materials and products that do not meet our specifications and quality control standards. These production difficulties and quality problems have in the past, and could in the future, result in stock outages or shortages in our markets with respect to such products, harm our sales, or create inventory write-downs for unusable products.

Our *ageLOC Me* personalized skin care system includes multiple new product formulations and a new proprietary hands-free dispenser. By gathering information from consumers through a series of questions on a mobile-device app, *ageLOC Me* enables consumers to personalize a daily regimen based on individual preferences and skin care needs. It is possible that the product formulations, dispenser and degree of customization will not meet consumers' expectations. Because of the novelty of this system, there could be manufacturing, quality control or other technical problems or consumer issues with the dispenser, and the product formulations and customization might not be compatible with consumers' skin sensitivities and selected preferences. The system contains a large number of SKUs, and there is a degree of unpredictability in forecasting inventory needs. Any problems with *ageLOC Me* or our other products could lead to an increase in product returns and negatively impact our reputation, revenue and profitability.

### Difficult economic conditions could harm our business.

Global economic conditions continue to be challenging. Difficult economic conditions could adversely affect our business by causing a decline in demand for our products, particularly if the economic conditions are prolonged or worsen. In addition, such economic conditions may adversely impact access to capital for us and our suppliers, may decrease the ability of our sales force and consumers to obtain or maintain credit cards, and may otherwise adversely impact our operations and overall financial condition. For example, the significant recent decline in Mainland China's stock market and other negative economic indicators have caused uncertainty regarding the potential for growth in Mainland China's economy. Continued declines in economic conditions in Mainland China could negatively impact our business and revenue in that market and in other markets globally.

Filed Aug 7, 2015.
Source: SEC EDGAR, the filing index for accession 0001021561-15-000062. Last ingested by Listed: Nov 5, 2026, 18:30 ET. No prices; not investment advice.
